LivaNova Corp (LIVN) Forward Price-to-Revenue Multiple

livanova.com (LIVN) - corporate logo

LivaNova PLC dominates epilepsy neuromodulation, leveraging inelastic demand and stable cash flow. The business's forward P/S illustrates patient brand loyalty regarding implant maintenance, where the value 2.50 represents the current figure. Predictable cash from cardiac surgery and steady operational momentum make the company a reliable asset whose long-term trend smooths out market noise.

LIVN livanova.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/15/2026

LivaNova PLC - analytical breakdowns and key metrics (LIVN)

- market price and analyst price targets:
Price Chart LivaNova Corp|LIVN - Analyst Median Target
- market capitalization details:
Market Valuation LivaNova plc|LIVN - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share LivaNova|LIVN - Company Net Assets|Market Capitalization to Book Value Ratio livanova.com|LIVN - Company Assets
- debt and solvency information:
Total Debt to Capital LivaNova PLC|LIVN - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital LivaNova plc|LIVN - Company Total Debt Obligations|Debts to Book Capitalization LivaNova plc|LIVN - Company Long-Term Liabilities|Company Short-Term Debts LivaNova|Quick Liquidity livanova.com
- business earnings and investment ratios data:
LIVN - Company Net Income|Future Profit LivaNova PLC|LIVN - Company Value to Net Income|Forward P/E Multiple LivaNova plc|LIVN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization LivaNova PLC|LIVN - Operating profit before depreciation charges|Net earnings per share for the last 12 months LivaNova|LIVN - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth livanova.com|LIVN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year LivaNova PLC
- sales and revenue data:
LIVN - Company Annual Revenue|Company Projected Revenue LivaNova Corp|LIVN - Market Cap to Revenue|Forward P/S Multiple LivaNova Corp
Comprehensive company analysis:LivaNova Corp LIVN
Product sample of LivaNova Corp

Forward P/S determines the market value of a company relative to expected sales, allowing an investor to assess the extent of overpayment for future cash flows. An analysis of the future P/S of LivaNova PLC reflects market expectations for growth in cardiology procedure volumes and the success of neuromodulation, confirming the company's fundamental stability amid the optimization of internal costs.

Competitors of LivaNova PLC (LIVN)

Stryker Inc - Forward Price-to-Revenue Multiple|Forward Price to Sales MDT|PHG - Price-to-Projected Revenue Ratio|Smith & Nephew plc (SNN) - Forward Price-to-Revenue Multiple|Hologic Inc (HOLX) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Carlisle (CSL)|ITGR (integer.net) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AdaptHealth LLC AHCO|Forward P/S Multiple SSII|Avanos Medical, Inc. - Market Cap to Projected Revenue|Forward P/S Multiple SI (Shoulder Innovations, Inc.)|VMD - Forward Price-to-Revenue Multiple|Inogen - Forward P/S Multiple|owletcare.com (OWLT) - Forward Price-to-Revenue Multiple|QIPT: Forward P/S Multiple|Precision Optics Corporation, Inc. (POCI) - Forward P/S Multiple|Price-to-Projected Revenue Ratio PAVmed Inc.|Price-to-Projected Revenue Ratio TIVC|Forward Price-to-Revenue Multiple MOVE (Movano Inc)|NUVO (Nuvo Cares) - Forward Price to Sales